BRNS
Barinthus Biotherapeutics
BRNS
BRNS
19 hedge funds and large institutions have $10.7M invested in Barinthus Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
2
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.4K |
| 2 |
Millennium Management
New York
|
+$12.5K |
| 3 |
BlackRock
New York
|
+$7.72K |
| 4 |
Morgan Stanley
New York
|
+$3.7K |
| 5 |
Renaissance Technologies
New York
|
+$3.33K |
